| PIRAMAL PHARMA  | 
Last 5 Year ShareHolding (%) History of PIRAMAL PHARMA
Last 8 Quarters| Sep2025 | Jun2025 | Mar2025 | Dec2024 | Sep2024 | Jun2024 | Mar2024 | Dec2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Promoter and Promoter Group | |||||||||
| Indian Promoters | 34.86 % | 34.86 % | 34.95 % | 34.95 % | 34.95 % | 34.95 % | 35.02 % | 35.02 % | |
| Individuals / Hindu Undivided Family | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | |
| Central Government/State Government(s) | - | - | - | - | - | - | - | - | |
| Bodies Corporate | 6.90 % | - | - | - | - | - | - | - | |
| Financial Institutions / Banks | - | - | - | - | - | - | - | - | |
| Partnership Firms | - | - | - | - | - | - | - | - | |
| Promoter Group | - | - | - | - | - | - | - | - | |
| Employees Welfare Fund | - | - | - | - | - | - | - | - | |
| Other | 27.76 % | 34.66 % | 34.75 % | 34.75 % | 34.75 % | 34.75 % | 34.83 % | 34.83 % | |
| Any Others (Specify) | - | - | - | - | - | - | - | - | |
| Foreign Promoters | - | - | - | - | - | - | - | - | |
| Non-Residents Individuals / Foreign Individuals | - | - | - | - | - | - | - | - | |
| 'Bodies Corporate | - | - | - | - | - | - | - | - | |
| Institutions | - | - | - | - | - | - | - | - | |
| Other | - | - | - | - | - | - | - | - | |
| Any Others (Specify) | - | - | - | - | - | - | - | - | |
| Total of Promoter and Promoter Group | 34.86 % | 34.86 % | 34.95 % | 34.95 % | 34.95 % | 34.95 % | 35.02 % | 35.02 % | |
| Pledged Promoter Holdings | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | |
| Public Shareholding | |||||||||
| Institutions | 45.16 % | 45.11 % | 46.26 % | 45.78 % | 45.53 % | 44.37 % | 42.71 % | 42.19 % | |
| Mutual Funds / UTI | 13.11 % | 12.32 % | 12.73 % | 11.66 % | 11.21 % | 10.12 % | 9.01 % | 6.28 % | |
| Financial Institutions / Banks | - | - | - | - | - | - | - | - | |
| Insurance Companies | 1.49 % | 1.67 % | 1.79 % | 2.13 % | 2.22 % | 2.43 % | 2.64 % | 2.88 % | |
| Foreign Institutional Investors | - | - | - | - | - | - | - | - | |
| Venture Capital Funds | - | - | - | - | - | - | - | - | |
| Foreign Venture Capital Investors | - | - | - | - | - | - | - | - | |
| Alternate Investment Funds | 0.29 % | 0.26 % | 0.26 % | 0.30 % | 0.37 % | 0.40 % | 0.47 % | 0.52 % | |
| Foreign Portfolio investors | 30.27 % | 30.86 % | 31.49 % | 31.68 % | 31.73 % | 31.41 % | 30.58 % | 32.51 % | |
|  Provident funds / Pension funds | - | - | - | - | - | - | - | - | |
| Multilateral & Bileteral Development Financial Institution | - | - | - | - | - | - | - | - | |
| Any Others (Specify) | - | - | - | - | - | - | - | - | |
| Central Government / State Government(s) | - | - | - | - | - | - | - | - | |
| Foreign Financial Institutions / Banks | - | - | - | - | - | - | - | - | |
| Stressed Assets Stabilisation Fund | - | - | - | - | - | - | - | - | |
| Foreign Financial Institutions | - | - | - | - | - | - | - | - | |
| State Finance Corporation | - | - | - | - | - | - | - | - | |
| Foreign Bodies DR | - | - | - | - | - | - | - | - | |
| Other | - | - | - | - | - | - | - | - | |
| Non-Institutions | 19.98 % | 20.03 % | 18.78 % | 19.27 % | 19.52 % | 20.69 % | 22.26 % | 22.79 % | |
| Bodies Corporate | 1.16 % | 1.27 % | 1.20 % | 1.23 % | 1.25 % | 1.48 % | 1.87 % | 1.83 % | |
| Individuals | - | - | - | - | - | - | - | - | |
| Individual shareholders holding nominal share capital up to Rs. 1 lakh | 10.50 % | 10.48 % | 9.53 % | 9.58 % | 9.50 % | 9.92 % | 10.48 % | 10.59 % | |
| Individual shareholders holding nominal share capital in excess of Rs. 1 lakh | 3.61 % | 3.60 % | 3.58 % | 3.71 % | 3.79 % | 4.01 % | 4.65 % | 4.98 % | |
| NBFCs Registed with RBI | - | - | - | - | - | - | - | - | |
| Employee Trusts | 0.51 % | 0.57 % | 0.34 % | 0.40 % | 0.45 % | 0.47 % | 0.37 % | 0.38 % | |
| Any Others (Specify) | - | 2.79 % | - | - | - | - | - | - | |
| Clearing Members | 0.03 % | 0.01 % | - | - | 0.01 % | - | - | 0.01 % | |
| Non Resident Indians | 1.09 % | 1.06 % | 1.07 % | 1.04 % | 1.08 % | 1.13 % | 1.09 % | 1.10 % | |
| Directors & their Relatives & Friends | 0.02 % | 0.02 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | |
| Foreign Collaborators | - | - | - | - | - | - | - | - | |
| Foreign Mutual Fund | - | - | - | - | - | - | - | - | |
| Trusts | 0.01 % | 0.01 % | - | - | - | 0.02 % | 0.02 % | 0.03 % | |
| Hindu Undivided Families | 0.43 % | 0.42 % | 0.40 % | 0.41 % | 0.44 % | 0.57 % | 0.65 % | 0.68 % | |
| Foreign Corporate Bodies | 1.30 % | 1.30 % | 1.31 % | 1.31 % | 1.31 % | 1.31 % | 1.31 % | 1.31 % | |
| Shares in transit | - | - | - | - | - | - | - | - | |
| Market Maker | - | - | - | - | - | - | - | - | |
| ESOP/ESOS/ESPS | - | - | - | - | - | - | - | - | |
| Societies | - | - | - | - | - | - | - | - | |
| Escrow Account | 0.58 % | 0.59 % | 0.61 % | 0.62 % | 0.63 % | 0.64 % | 0.65 % | 0.65 % | |
| Any Other | 0.72 % | 0.70 % | 0.71 % | 0.95 % | 1.04 % | 1.11 % | 1.17 % | 1.23 % | |
| Total Public Shareholding | 65.14 % | 65.14 % | 65.05 % | 65.05 % | 65.05 % | 65.05 % | 64.98 % | 64.98 % | |
| - | - | - | - | - | - | - | - | ||
| Total of Promoter and Public Shareholding | 100.00 % | 100.00 % | 100.00 % | 100.00 % | 100.00 % | 100.00 % | 100.00 % | 100.00 % | |
Compare ShareHolding of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹26,550.8 Cr | -1.7% | 4.6% | -18.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| PIRAMAL PHARMA | -1.7% | 4.6% | -18.1% | 
| SENSEX | -0.3% | 4.5% | 5.7% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    